Interview with Dr. Martin Gershon, Senior Strategic Advisor at Pepper Bio

Tell us a bit about your background. First, I have to start by saying how appreciative I am because I’ve always had exceptional people supporting me and advising me in my career path. I would say that what I am doing now is an amalgam of all the pieces of the mosaic of my life journey which has been dedicated to improving the healthcare system and advancing the development of…

Comments Off on Interview with Dr. Martin Gershon, Senior Strategic Advisor at Pepper Bio

See Pepper Bio’s 20-slide pitch deck that got Merck to back an AI-powered biotech creating drugs for untreatable diseases

Pepper Bio landed $6.5 million in seed funding led by NFX. The startup wants to improve the drug-discovery process for pharma companies using AI. Pepper Bio is also developing treatments itself and expects to begin clinical trials next year. Drug discovery is expensive and time-consuming for pharmaceutical and biotech companies. From identifying the right biological targets implicated in a disease, to developing drugs that impact those targets through years-long clinical…

Comments Off on See Pepper Bio’s 20-slide pitch deck that got Merck to back an AI-powered biotech creating drugs for untreatable diseases

Salt Burn: NFX and Merck Seed Pepper Bio to Develop Drugs with Transomics

By Jonathan D. Grinstein, PhD My interview with Pepper Bio CEO Jon Hu begins with one of the most frequently repeated phrases I hear when speaking with drug developers: “We are a drug developer trying to tackle untreatable diseases,” Hu says. In Hu’s opinion, however, Pepper Bio’s computational approach that uses “functional” omics data, which they’ve dubbed “transomics,” will set them apart in their quest to combat incurable diseases. So…

Comments Off on Salt Burn: NFX and Merck Seed Pepper Bio to Develop Drugs with Transomics

‘Transomics’ Drug-Discovery Startup Pepper Bio Raises $6.5M

NEW YORK — Drug discovery and bioinformatics startup Pepper Bio said on Thursday that it has raised $6.5 million in seed funding. The financing round was led by NFX and included Silverton Partners, Merck Digital Sciences Studio, Mana Ventures, Tensility Ventures, and VSC Ventures. Pepper Bio was founded in 2020 through a Merck-run accelerator program to leverage a multiomics approach — dubbed transomics — to identify new therapeutics, repurpose existing ones, and…

Comments Off on ‘Transomics’ Drug-Discovery Startup Pepper Bio Raises $6.5M

The ‘COMPASS’ That’s Aiding Pepper Bio’s Innovative Drug Discovery Route

In the heart of Boston, amidst the intellectual hum of scientific innovation, Pepper Bio, self-styled as the "Google Maps for drug discovery," has emerged as a groundbreaking entity in the realm of pharmaceutical exploration. On November 30, 2023, the company proudly announced an impressively oversubscribed seed funding round, amassing $6.5 million. This financial infusion, spearheaded by NFX and bolstered by contributions from an array of investors including Silverton Partners, Merck Digital Sciences Studio,…

Comments Off on The ‘COMPASS’ That’s Aiding Pepper Bio’s Innovative Drug Discovery Route

Drug discovery startup Pepper Bio hopes to challenge Eroom’s law with new funding

Whether you are a tech optimist or not, you have to acknowledge that progress rarely follows a straight line. While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant diseases, and the process isn’t getting cheaper. Some hope that AI can help, and it likely will — when it comes to biotech, it is much more than a buzzword. But Boston-based drug discovery…

Comments Off on Drug discovery startup Pepper Bio hopes to challenge Eroom’s law with new funding